Aerovate Therapeutics, Inc. (AVTE)
NASDAQ: AVTE · Real-Time Price · USD
2.610
-0.050 (-1.88%)
At close: Nov 21, 2024, 4:00 PM
2.550
-0.060 (-2.30%)
After-hours: Nov 21, 2024, 5:16 PM EST
Aerovate Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for AVTE stock have an average target of 11.75, with a low estimate of 2.00 and a high estimate of 41. The average target predicts an increase of 350.19% from the current stock price of 2.61.
Analyst Consensus: Hold
* Price targets were last updated on Jun 18, 2024.
Analyst Ratings
The average analyst rating for AVTE stock from 7 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 6 | 6 | 6 | 6 | 6 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Buy → Hold Downgrades $27 → $2 | Buy → Hold | Downgrades | $27 → $2 | -23.37% | Jun 18, 2024 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jun 18, 2024 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $35 → $2 | Buy → Hold | Downgrades | $35 → $2 | -23.37% | Jun 18, 2024 |
| TD Cowen | TD Cowen | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jun 18, 2024 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $65 → $2 | Strong Buy → Hold | Downgrades | $65 → $2 | -23.37% | Jun 17, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.84
from -2.87
EPS Next Year
-1.02
from -2.84
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | ||
| Avg | n/a | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -2.16 | -0.17 | -0.84 |
| Avg | -2.84 | -1.02 | -2.31 |
| Low | -3.53 | -2.03 | -3.27 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.